1. Evolutionary dynamics of residual disease in human glioblastoma. (19th November 2018) Authors: Spiteri, I; Caravagna, G; Cresswell, G D; Vatsiou, A; Nichol, D; Acar, A; Ermini, L; Chkhaidze, K; Werner, B; Mair, R; Brognaro, E; Verhaak, R G W; Sanguinetti, G; Piccirillo, S G M; Watts, C; Sottoriva, A Journal: Annals of oncology Issue: Volume 30:Number 3(2019) Page Start: 456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P01.009 Micro-infiltration before growth: the inverse paradigm of primary glioblastoma is crucial to overcome resistance and develop effective therapies. (19th September 2018) Authors: Brognaro, E Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P04.05 "The Development Tumor Model" used to reproduce and follow glioblastoma evolution in the whole brain and to test and monitor novel therapies. (19th September 2018) Authors: Brognaro, E Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P14.19 The inverse paradigm of IDH-wildtype glioblastoma is fundamental to overcome the two causes of resistance and develop novel effective therapies. (6th September 2019) Authors: Brognaro, E Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗